Gainers & Losers
Thu Mar 12 2026 09:59:59- NTPC share price
- ₹390.452.75%
- Power Grid Corporation of ...
- ₹303.701.64%
- Tech Mahindra share price
- ₹1,349.801.19%
- HCL Technologies share price
- ₹1,357.700.57%
Active Stocks
Thu Mar 12 2026 10:29:49- Eternal share price
- ₹221.25-1.14%
- Suzlon Energy share price
- ₹42.462.04%
- Adani Power share price
- ₹149.107.38%
- Yes Bank share price
- ₹19.31-1.13%
- Tata Power Company share price
- ₹402.304.44%
Mankind Pharma Profit & Loss Annual
2,206.10 -37.35 (-1.66%)Updated : 12 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 9,638.64 | 8,123.36 | 7,174.72 | 5,929.56 |
| Other Net | 76.40 | 77.29 | 50.05 | 12.06 |
| Diluted Weighted Average Shares | 40.47 | 40.12 | 40.06 | 40.06 |
| Gain( Loss)on Saleof Assets | 7.91 | 9.45 | 10.31 | 3.12 |
| Depreciation/ Amortization | 621.18 | 378.37 | 325.86 | 166.56 |
| Total Extraordinary Items | 4.53 | 0.98 | - | - |
| Operating Income | 2,568.80 | 2,137.08 | 1,574.72 | 1,851.99 |
| Net Income | 1,990.96 | 1,912.90 | 1,281.86 | 1,433.48 |
| Income Availableto Com Excl Extra Ord | 1,986.43 | 1,911.92 | 1,281.86 | 1,433.48 |
| Other Operating Expenses Total | 96.18 | 61.15 | - | - |
| Net Income Before Taxes | 2,516.33 | 2,397.94 | 1,671.24 | 1,974.60 |
| Minority Interest | -20.16 | -28.87 | -27.82 | -19.48 |
| Interest Exp( Inc) Net- Operating Total | -2.72 | 0.05 | 0.05 | 0.05 |
| Net Income After Taxes | 2,006.59 | 1,940.79 | 1,309.68 | 1,452.96 |
| Income Availableto Com Incl Extra Ord | 1,990.96 | 1,912.90 | 1,281.86 | 1,433.48 |
| Costof Revenue Total | 3,718.67 | 3,382.47 | 3,071.29 | 2,573.14 |
| Gross Profit | 8,488.77 | 6,877.97 | 5,678.15 | 5,208.42 |
| Interest Inc( Exp) Net- Non- Op Total | -136.78 | 174.12 | 36.16 | 107.44 |
| Unusual Expense( Income) | -159.61 | 4.69 | 13.56 | -19.75 |
| Diluted Net Income | 1,990.96 | 1,912.90 | 1,281.86 | 1,433.48 |
| Provisionfor Income Taxes | 509.74 | 457.15 | 361.56 | 521.64 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 1,986.43 | 1,911.92 | 1,281.86 | 1,433.48 |
| Total Revenue | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 |
| Selling/ General/ Admin Expenses Total | 5,364.94 | 4,296.63 | 3,763.95 | 3,209.56 |
| Diluted Normalized EPS | 45.78 | 47.56 | 32.06 | 35.36 |
| Diluted EPS Excluding Extra Ord Items | 49.08 | 47.66 | 32.00 | 35.78 |
*All figures in crores except per share values
Mankind Pharma Quick Links
Mankind Pharma Dividend Mankind Pharma Bonus Mankind Pharma News Mankind Pharma AGM Mankind Pharma Rights Mankind Pharma Splits Mankind Pharma Board Meetings Mankind Pharma Key Metrics Mankind Pharma Shareholdings Mankind Pharma Balance Sheet Mankind Pharma Cashflow Mankind Pharma Q1 Results Mankind Pharma Q2 Results Mankind Pharma Q3 Results Mankind Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,824.90+11.90(0.66%)
378.50+1.20(0.32%)
893.15-47.10 (-5.01%)
1,259.05-56.00 (-4.26%)